marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
VistaGen Therapeutics Financial Ratios 2011-2024 | VTGN
Annual Financial Ratios VistaGen Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.5 | -0.2 | -1.2 | -0.9 | -0.9 | -1.2 | -1.0 | -1.5 | -0.3 | -0.8 | -3.6 | -1.2 | -3.0 | - |
P/S |
68.6 | 66.8 | 64.7 | 26.4 | - | - | - | 11.9 | - | - | - | 79.5 | 27.4 | - |
EPS |
-1.5 | -8.5 | -1.4 | -1.6 | -0.5 | -0.9 | -1.1 | -1.5 | -29.1 | -10.5 | -2.7 | -1.3 | - | - |
EV (Enterprise Value) |
-36.8 M | 4.13 M | -46.6 M | -77.4 M | 29.4 M | 24.4 M | 7.87 M | 15.1 M | 18.6 M | 31.4 M | 23.6 M | 28.7 M | 42.8 M | -139 K |
EBITDA per Share |
-1.7 | -8.5 | -1.39 | -1.55 | -0.472 | -0.857 | -1.02 | -1.35 | -10.1 | -5.09 | -4.53 | -7.46 | -12.2 | - |
EV/EBITDA |
0.0 | -0.9 | -0.7 | -0.3 | -1.2 | -0.8 | -3.7 | -3.5 | -3.1 | -4.4 | - | |||
PEG |
-0.02 | -0.0 | -0.04 | -0.08 | 0.02 | 0.06 | 0.04 | 0.02 | -0.0 | -0.0 | 0.04 | -0.02 | -0.0 | - |
P/B |
0.6 | 1.0 | 0.2 | 0.1 | -3.4 | 4.3 | 2.0 | 24.2 | -5.0 | -0.5 | -0.8 | -1.3 | -6.5 | - |
P/CF |
-2.8 | -0.2 | -0.3 | -0.8 | -1.2 | -2.1 | -1.5 | -2.0 | -3.1 | -3.9 | -4.9 | -4.4 | -10.2 | - |
ROE % |
-25.69 | -490.46 | -15.08 | -11.45 | 362.59 | -347.55 | -207.41 | -1665.39 | 1586.07 | 67.59 | 23.19 | 102.63 | 213.99 | - |
ROA % |
-23.75 | -280.94 | -13.08 | -9.73 | -359.89 | -175.49 | -127.20 | -276.26 | -4770.71 | -5148.61 | -1125.41 | -1461.91 | -3574.21 | - |
ROCE % |
-28.89 | -490.63 | -14.18 | -10.12 | -693.14 | -219.04 | -144.60 | -437.10 | 2217.69 | 39.59 | 101.76 | 443.14 | 318.40 | - |
Current Ratio |
13.2 | 2.3 | 7.5 | 6.6 | 0.6 | 4.9 | 7.6 | 2.5 | 0.5 | 0.0 | 0.0 | 0.3 | 0.1 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | 28.9 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios VistaGen Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.42 | -0.35 | -0.22 | -0.66 | -0.94 | - | -1.42 | -2.54 | -2.87 | -0.08 | -0.05 | -0.16 | -0.11 | -0.2 | -0.07 | -0.07 | -0.05 | -0.07 | -0.15 | -0.15 | -0.13 | -0.15 | -0.24 | -0.24 | -0.3 | -0.19 | -0.25 | -0.53 | -0.28 | -0.28 | -0.34 | -0.34 | -0.42 | -0.51 | -1.95 | -5.26 | -5.26 | -4.24 | -0.84 | -0.84 | -1.58 | -1.57 | 0.12 | 0.12 | -1.35 | 0.01 | -0.85 | -1.11 | -0.11 | - | - | - | - | - |
EBITDA per Share |
- | -0.4 | - | - | -0.95 | - | -1.41 | -2.52 | -2.87 | -0.08 | -0.05 | -0.16 | -0.11 | -0.04 | -0.07 | -0.07 | -0.05 | -0.06 | -0.14 | -0.14 | -0.12 | -0.15 | -0.23 | -0.23 | -0.29 | -0.18 | -0.21 | -0.5 | -0.25 | -0.25 | -0.31 | -0.31 | -0.38 | -0.39 | -1.21 | -1.29 | -3.3 | -1.24 | -0.86 | -0.83 | -0.85 | - | -1.3 | -1.31 | -1.12 | - | -0.1 | -0.11 | -0.1 | -0.09 | -0.17 | -0.18 | -0.12 | -0.31 |
ROE % |
-47.81 | -134.66 | -171.63 | -213.70 | -254.27 | -149.21 | -175.00 | -140.96 | -120.43 | -86.53 | -67.50 | -59.97 | -27.09 | -96.15 | -33.68 | 69.78 | 173.24 | 398.32 | -39.36 | -563.50 | -1087.64 | -1421.00 | -1098.01 | -700.96 | 24.30 | 583.95 | 275.06 | 202.43 | -161.06 | -584.65 | -150.72 | 85.52 | 312.10 | 608.35 | 686.00 | 557.80 | 402.06 | 169.26 | 61.11 | 53.86 | 46.55 | 45.64 | 8.59 | 60.41 | 144.06 | 162.96 | 196.44 | 240.23 | 209.20 | 210.01 | 185.34 | 51.58 | 31.93 | 7.33 |
ROA % |
-42.56 | -75.83 | -99.23 | -127.25 | -154.59 | -109.49 | -131.84 | -110.62 | -98.59 | -72.37 | -55.75 | -48.96 | -44.18 | -90.20 | -138.63 | -245.61 | -287.71 | -275.45 | -265.60 | -249.72 | -262.67 | -311.52 | -303.36 | -228.51 | -338.24 | -341.12 | -365.97 | -389.77 | -236.43 | -178.90 | -316.61 | -378.42 | -451.92 | -820.70 | -11568.97 | -11882.48 | -12053.20 | -11913.29 | -2692.98 | -2232.94 | -1918.87 | -1992.67 | -195.56 | -1871.89 | -3160.63 | -3125.77 | -3403.32 | -2892.62 | -2473.70 | -2304.43 | -2842.38 | -837.56 | -133.94 | -745.09 |
ROCE % |
-34.52 | -98.23 | -119.39 | -157.81 | -191.02 | -128.59 | -152.82 | -126.94 | -110.05 | -91.38 | -73.12 | -65.58 | -36.98 | -40.65 | -134.77 | -378.87 | -650.72 | -748.11 | -756.04 | -636.40 | -495.67 | -477.50 | -411.00 | -303.75 | -848.78 | -902.67 | -957.55 | -1001.21 | -370.55 | -256.06 | 84.27 | 2546.11 | 3111.18 | 3505.44 | 3272.16 | 886.81 | 389.37 | 58.93 | 74.00 | 106.18 | 139.88 | 167.95 | 169.91 | 212.40 | 237.66 | 234.05 | 174.02 | 245.57 | 219.84 | 221.66 | 260.42 | 50.39 | 46.80 | 6.39 |
Current Ratio |
10.8 | 13.0 | 16.8 | 6.4 | 1.8 | 2.3 | 3.3 | 3.7 | 4.6 | 7.5 | 8.6 | 5.1 | 5.7 | 6.6 | 7.1 | 1.3 | 0.5 | 0.5 | 0.5 | 0.7 | 1.1 | 2.0 | 1.3 | 1.8 | 1.6 | 2.6 | 3.6 | 0.6 | 0.8 | 1.2 | 1.8 | 2.4 | 3.4 | 0.2 | 0.6 | 0.6 | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.7 | 24.5 | 25.9 | 3076.0 | 5239.0 | 27.5 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.7 | 24.5 | 25.9 | 3076.0 | 5239.0 | 27.5 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.7 | 24.5 | 25.9 | 3076.0 | 5239.0 | 27.5 | - |
All numbers in USD currency